These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
456 related articles for article (PubMed ID: 15493567)
1. The androgenic profile of women with non-insulin-dependent diabetes mellitus. Tok EC; Ertunc D; Evruke C; Dilek S J Reprod Med; 2004 Sep; 49(9):746-52. PubMed ID: 15493567 [TBL] [Abstract][Full Text] [Related]
2. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism. Hassa H; Tanir HM; Yildiz Z Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383 [TBL] [Abstract][Full Text] [Related]
3. [[Low birth weight, adrenal and sex hormones and their correlation with carbohydrate metabolism and cardiovascular physiology, investigated in young adulthood] ]. Szathmári M; Reusz G; Tulassay T Orv Hetil; 2000 Sep; 141(36):1967-73. PubMed ID: 11031833 [TBL] [Abstract][Full Text] [Related]
4. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism. Toscano V; Bianchi P; Balducci R; Guglielmi R; Mangiantini A; Lubrano C; Sciarra F Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185 [TBL] [Abstract][Full Text] [Related]
5. Plasma selenium levels in Turkish women with polycystic ovary syndrome. Coskun A; Arikan T; Kilinc M; Arikan DC; Ekerbiçer HÇ Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):183-6. PubMed ID: 23490536 [TBL] [Abstract][Full Text] [Related]
6. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome. Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560 [TBL] [Abstract][Full Text] [Related]
7. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325 [TBL] [Abstract][Full Text] [Related]
8. Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls. Panidis D; Farmakiotis D; Koliakos G; Rousso D; Kourtis A; Katsikis I; Asteriadis C; Karayannis V; Diamanti-Kandarakis E Hum Reprod; 2005 Aug; 20(8):2127-32. PubMed ID: 15890737 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism. Bertoli A; Fusco A; Magnani A; Marini MA; Di Daniele N; Gatti S; Lauro R Exp Clin Endocrinol Diabetes; 1995; 103(1):15-20. PubMed ID: 7621099 [TBL] [Abstract][Full Text] [Related]
10. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels. Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364 [TBL] [Abstract][Full Text] [Related]
11. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. Dunaif A; Mandeli J; Fluhr H; Dobrjansky A J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783 [TBL] [Abstract][Full Text] [Related]
12. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects. Meczekalski B; Slopien R; Warenik-Szymankiewicz A Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812 [TBL] [Abstract][Full Text] [Related]
13. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism. Ozdemir S; Ozdemir M; Görkemli H; Kiyici A; Bodur S Acta Obstet Gynecol Scand; 2010; 89(2):199-204. PubMed ID: 19900078 [TBL] [Abstract][Full Text] [Related]
14. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Holte J; Bergh T; Gennarelli G; Wide L Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus. Kelestimur F; Unluhizarci K; Baybuga H; Atmaca H; Bayram F; Sahin Y Fertil Steril; 2006 Aug; 86(2):405-10. PubMed ID: 16762349 [TBL] [Abstract][Full Text] [Related]
16. Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne. Timpatanapong P; Rojanasakul A J Dermatol; 1997 Apr; 24(4):223-9. PubMed ID: 9164062 [TBL] [Abstract][Full Text] [Related]
17. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276 [TBL] [Abstract][Full Text] [Related]
18. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism. Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298 [TBL] [Abstract][Full Text] [Related]
19. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease. Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705 [TBL] [Abstract][Full Text] [Related]
20. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist? Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho J; Varela C Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]